Company Filing History:
Years Active: 1994-2003
Title: The Innovations of Cary S. Yonce
Introduction
Cary S. Yonce is a notable inventor based in Newtown, Pennsylvania. He has made significant contributions to the field of medicine, particularly in the area of cardiovascular health. With a total of four patents to his name, Yonce's work focuses on innovative methods for preventing and treating atherosclerosis and hypertension.
Latest Patents
Yonce's latest patents include a method for preventing, stabilizing, or causing regression of atherosclerosis. This method employs a combination of a cholesterol-lowering drug and an ACE inhibitor. Specifically, it aims to slow the progression of atherosclerosis in hypertensive or normotensive patients by administering a cholesterol-lowering drug such as pravastatin, along with an ACE inhibitor like captopril or zofenopril. Another significant patent addresses the prevention of hypertension in normotensive patients with insulin resistance. This method also utilizes a cholesterol-lowering drug, such as pravastatin, either alone or in combination with an ACE inhibitor.
Career Highlights
Cary S. Yonce is currently associated with E.R. Squibb & Sons, Inc., where he continues to innovate in the pharmaceutical field. His work has been instrumental in developing treatments that address critical health issues related to cardiovascular diseases.
Collaborations
Yonce has collaborated with notable colleagues, including Werner Tschollar and James L. Bergey. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Cary S. Yonce's contributions to medical innovation, particularly in cardiovascular health, highlight his role as a significant inventor. His patents reflect a commitment to improving patient outcomes through effective treatment methods.